Quince Therapeutics QNCX 深 沪
已收盘 10-09 16:00:00 美东时间
31.73
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 31.73
- 总市值 3227.14万
- 52周最高 909.98
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 15.80
- 委 比 0.00%
- 总股本 101.71万
- 历史最高 24396.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 16.00
- 每 手 1
- 风险率 258.65%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅91.5%！巴克莱上调Vertical Aerospace评级至"标配"，目标价下调至1美元
今日重点评级关注：巴克莱：上调Vertical Aerospace评级至"标配"，目标价从2美元降至1美元；巴克莱：维持Bitdeer Technologies"超配"评级，目标价从15美元升至17美元
10-12 14:52
Raymond James Initiates Coverage On Quince Therapeutics with Outperform Rating, Announces Price Target of $72
Raymond James analyst Tiago Fauth initiates coverage on Quince Therapeutics (NASDAQ:QNCX) with a Outperform rating and announces Price Target of $72.
10-09 19:25
Quince Therapeutics Announces Conditional Board Restructuring Plans
Quince Therapeutics ( ($QNCX) ) has shared an announcement. On September 30, 20...
10-02 19:58
美股大行评级 | Meta获4家机构齐升目标价，最高看至995美元！麦当劳遭6家机构下调，最低看至260美元
今日重点评级关注：Canaccord Genuity：维持Aurora Innovation"买入"评级，目标价从15美元升至17美元；摩根大通：维持皇家加勒比邮轮"超配"评级，目标价从345美元升至394美元
09-25 15:55
Rodman & Renshaw Initiates Coverage On Quince Therapeutics with Buy Rating, Announces Price Target of $70
Rodman & Renshaw analyst Seema Sheoran initiates coverage on Quince Therapeutics (NASDAQ:QNCX) with a Buy rating and announces Price Target of $70.
09-24 19:41
美股大行评级 | Muse热度发酵，Meta目标价获大幅升至875美元；闪迪获看好至2400美元，潜在升幅约27%
今日重点评级关注：Citizens：上调Quince Therapeutics评级至"跑赢大市"，目标价77美元；康托·菲茨杰拉德：维持塞德斯医疗"超配"评级，目标价从61美元升至72美元
09-23 15:30
Quince Therapeutics Divests Italian Subsidiary, Refocuses Strategy
Quince Therapeutics ( ($QNCX) ) has issued an announcement. On September 8, 202...
09-15 05:45
Quince Therapeutics Faces Nasdaq Listing Compliance Challenges
An announcement from Quince Therapeutics ( ($QNCX) ) is now available. On Augus...
09-04 20:59
Quince Therapeutics Announces Planned Presidential Leadership Transition
Quince Therapeutics ( ($QNCX) ) has shared an update. Quince Therapeutics, Inc....
08-28 05:02
